Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research

被引:72
作者
Cheung, Yin Ting [1 ,2 ]
Lim, Si Rong [1 ]
Ho, Han Kiat [1 ]
Chan, Alexandre [1 ,2 ]
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore
[2] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore
关键词
CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; BREAST-CANCER PATIENTS; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; ADJUVANT CHEMOTHERAPY; ANTIOXIDANT ENZYMES; INTERFERON-ALPHA; DRUG ADRIAMYCIN;
D O I
10.1371/journal.pone.0081234
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: While various clinical and pharmacological determinants for chemotherapy-associated cognitive impairment have been identified, conflicting evidence suggests that cytokines might play an intermediary role. The objective of this systematic review was to evaluate the current evidence pertaining to the associations among chemotherapy, cytokines induction and cognitive impairment in cancer patients. Methods: A literature search with PubMed and SciVerse Scopus was conducted in March 2013 to gather relevant articles and abstracts that fulfilled the inclusion and exclusion criteria. This review included studies that had performed objective and/or subjective cognitive assessments and cytokine measurements on defined populations of cancer patients who received chemotherapy. Results: High methodological heterogeneity existed among the selected studies which differed in cancer populations, subject characteristics, cognitive endpoints, types of cytokines tested and their measurement methods. Weak to moderate correlations were observed between IL-1 beta, IL-6, TNF-alpha levels, and different degrees of cognitive impairment. Different types of chemotherapy treatments might lead to varying presentations and severities of cytokine-induced cognitive impairment. Notably, the time concordance between the onset of cytokine induction and occurrence of cognitive impairment was not well elucidated. A number of confounding factors was identified to interfere with the expression levels of cytokines; these confounders included subjects' cancer types, ages, genders, genetics and psychosocial characteristics such as anxiety, depression and fatigue. Conclusion: Although existing studies observed cognitive impairment and cytokine dysregulation in patients who receive chemotherapy, our results suggest that the intermediary role of cytokines in post-chemotherapy cognitive impairment is still controversial and requires further evaluation. A list of methodological recommendations is proposed to harmonize future studies of this subject matter.
引用
收藏
页数:12
相关论文
共 103 条
[81]   Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients [J].
Schagen, SB ;
Muller, MJ ;
Boogerd, W ;
Rosenbrand, RM ;
van Rhijn, D ;
Rodenhuis, S ;
van Dam, FSAM .
ANNALS OF ONCOLOGY, 2002, 13 (09) :1387-1397
[82]   The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review [J].
Schubert, Christian ;
Hong, Suzi ;
Natarajan, Loki ;
Mills, Paul J. ;
Dimsdale, Joel E. .
BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (04) :413-427
[83]   Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research [J].
Seigers, Riejanne ;
Fardell, Joanna E. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2011, 35 (03) :729-741
[84]   Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release [J].
Seigers, Riejanne ;
Timmermans, Jessica ;
van der Horn, Hans J. ;
de Vries, Erik F. J. ;
Dierckx, Rudi A. ;
Visser, Lydia ;
Schagen, Sanne B. ;
van Dam, Frits S. A. M. ;
Koolhaas, Jaap M. ;
Buwalda, Bauke .
BEHAVIOURAL BRAIN RESEARCH, 2010, 207 (02) :265-272
[85]   Cytokines and their relationship to the symptoms and outcome of cancer [J].
Seruga, Bostjan ;
Zhang, Haibo ;
Bernstein, Lori J. ;
Tannock, Ian F. .
NATURE REVIEWS CANCER, 2008, 8 (11) :887-899
[86]   Construct and concurrent validity of the Hopkins Verbal Learning Test - Revised [J].
Shapiro, AM ;
Benedict, RHB ;
Schretlen, D ;
Brandt, J .
CLINICAL NEUROPSYCHOLOGIST, 1999, 13 (03) :348-358
[87]   Central and peripheral nervous system toxicity of common chemotherapeutic agents [J].
Sioka, Chrissa ;
Kyritsis, Athanassios P. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) :761-767
[88]   Adriamycin-induced, TNF-α-mediated central nervous system toxicity [J].
Tangpong, Jitanjong ;
Cole, Marsha P. ;
Sultana, Rukhsana ;
Joshi, Gururaj ;
Estus, Steven ;
Vore, Mary ;
Clair, William St. ;
Ratanachaiyavong, Suvina ;
Clair, Daret K. St. ;
Butterfield, D. Allan .
NEUROBIOLOGY OF DISEASE, 2006, 23 (01) :127-139
[89]   Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain [J].
Tangpong, Jitbanjong ;
Cole, Marsha P. ;
Sultana, Rukhsana ;
Estus, Steven ;
Vore, Mary ;
St. Clair, William ;
Ratanachaiyavong, Suvina ;
St. Clair, Daret K. ;
Butterfield, D. Allan .
JOURNAL OF NEUROCHEMISTRY, 2007, 100 (01) :191-201
[90]   Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women [J].
Unfer, Tais C. ;
Conterato, Greicy M. M. ;
da Silva, Joao C. N. ;
Duarte, Marta M. M. F. ;
Emanuelli, Tatiana .
CLINICA CHIMICA ACTA, 2006, 369 (01) :73-77